<scp>DaxibotulinumtoxinA</scp> for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program

Authors

Todd M. Gross (ORCID: https://orcid.org/0000-0001-5482-5313)
Conor J. Gallagher (ORCID: https://orcid.org/0000-0002-5488-6594)
David Hollander
Rashid Kazerooni (ORCID: https://orcid.org/0000-0003-3223-2597)
Han S. Lee
Laxman Bahroo (ORCID: https://orcid.org/0000-0003-4264-0658)
Peter J. McAllister
Julia Sparrow
Robert A. Hauser
Aaron Ellenbogen
Atul T. Patel

Institutions

Georgetown University (US)
University of South Florida (US)
MedStar Georgetown University Hospital (US)
Quest Research Institute (US)
New England Institute for Neurology and Headache (US)
Kaiser Permanente San Leandro Medical Center (US)
Covance (United States) (US)

Publication Details

Journal: Movement Disorders Clinical Practice
Published: 2026-02-03
DOI: https://doi.org/10.1002/mdc3.70477
Primary Topic: Botulinum Toxin and Related Neurological Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Sanofi
Biogen
Teva Pharmaceutical Industries
F. Hoffmann-La Roche
Boston Scientific Corporation
Jazz Pharmaceuticals
Parkinson's Foundation
Acorda Therapeutics
Neurocrine Biosciences
Sage Therapeutics
Supernus Pharmaceuticals
Revance
Amneal Pharmaceuticals
Serina Therapeutics
Mitsubishi Tanabe Pharma Corporation
Ipsen
Genentech
Parkinsonfonden
UCB Pharma

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program

Todd M. Gross, Conor J. Gallagher, David Hollander, Rashid Kazerooni et al.

Feb 3, 2026

Movement Disorders Clinical Practice

Botulinum Toxin and Related Neurological Disorders

article

DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program

Todd M. Gross, Conor J. Gallagher, David Hollander, Rashid Kazerooni, Han S. Lee, Laxman Bahroo, Peter J. McAllister, Julia Sparrow, Robert A. Hauser, Aaron Ellenbogen, Atul T. Patel

February 3, 2026article en

Abstract

No abstract available for this paper.

Movement Disorders Clinical Practice

Georgetown University (US), University of South Florida (US), MedStar Georgetown University Hospital (US), Quest Research Institute (US), New England Institute for Neurology and Headache (US), Kaiser Permanente San Leandro Medical Center (US), Covance (United States) (US)

Sanofi, Biogen, Teva Pharmaceutical Industries, F. Hoffmann-La Roche, Boston Scientific Corporation, Jazz Pharmaceuticals, Parkinson's Foundation, Acorda Therapeutics, Neurocrine Biosciences, Sage Therapeutics, Supernus Pharmaceuticals, Revance, Amneal Pharmaceuticals, Serina Therapeutics, Mitsubishi Tanabe Pharma Corporation, Ipsen, Genentech, Parkinsonfonden, UCB Pharma

Openalex Percentile: Top 68%

Botulinum Toxin and Related Neurological Disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<scp>DaxibotulinumtoxinA</scp> for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real‐World Early Experience Program — Todd M. Gross, Conor J. Gallagher, et al. · Movement Disorders Clinical Practice (2026) | TGRS Research Map | TGRS